{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:00:27Z","timestamp":1791460827209,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["AZV NU21-07-00550"],"award-info":[{"award-number":["AZV NU21-07-00550"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["GA UK 488122"],"award-info":[{"award-number":["GA UK 488122"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV-2025-260776"],"award-info":[{"award-number":["SVV-2025-260776"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118542","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:32:01Z","timestamp":1758094321000},"page":"118542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration"],"prefix":"10.1016","volume":"192","author":[{"given":"Jan","family":"Melek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Sta\u0148kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-9722","authenticated-orcid":false,"given":"Eva","family":"Peterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumisang Edward","family":"Maseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"\u0160palkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1707-357X","authenticated-orcid":false,"given":"Reem","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0936-5602","authenticated-orcid":false,"given":"Ahmed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-2732","authenticated-orcid":false,"given":"Moustafa","family":"Elkalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Podhola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u017eb\u011bta","family":"\u0160tefela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"\u010cervinkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-4196","authenticated-orcid":false,"given":"Petr","family":"P\u00e1vek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Ku\u010dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118542_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118542_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118542_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","article-title":"Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease","volume":"11","author":"Legaki","year":"2022","journal-title":"Curr. Obes. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2025.118542_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094256","article-title":"Mitochondrial dysfunction as a pathogenesis and therapeutic strategy for Metabolic-Dysfunction-Associated steatotic liver disease","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118542_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031101","article-title":"Adaptation of mitochondrial substrate flux in a mouse model of nonalcoholic fatty liver disease","volume":"21","author":"Stankova","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118542_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121943","article-title":"The emerging significance of mitochondrial targeted strategies in NAFLD treatment","volume":"329","author":"Zhang","year":"2023","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118542_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/egh.11.11","article-title":"Mitochondrial dysfunction in nonalcoholic steatohepatitis","volume":"5","author":"Serviddio","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118542_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2025.118542_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2025.118542_bib10","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1053\/j.gastro.2017.01.014","article-title":"Farnesoid x receptor activation promotes hepatic amino acid catabolism and ammonium clearance in mice","volume":"152","author":"Massafra","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid x receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.biopha.2025.118542_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12272-016-0812-y","article-title":"Farnesoid x receptor as a regulator of fuel consumption and mitochondrial function","volume":"39","author":"Han","year":"2016","journal-title":"Arch. Pharm. Res"},{"issue":"16","key":"10.1016\/j.biopha.2025.118542_bib13","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/jm0002127","article-title":"Identification of a chemical tool for the orphan nuclear receptor FXR","volume":"43","author":"Maloney","year":"2000","journal-title":"J. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118542_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib15","first-page":"223","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention, nature reviews","volume":"18","author":"Huang","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/mol.110.064501","article-title":"Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid x receptor and TGR5 agonist","volume":"78","author":"Rizzo","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118542_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","author":"Tacke","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2025.118542_bib18","doi-asserted-by":"crossref","unstructured":"A.J. Sanyal, R. Loomba, Q.M. Anstee, V. Ratziu, K.V. Kowdley, E.J. Lawitz, C. White, S. Sawhney, T. Capozza, R. Leyva, Final results from the phase 3 REGENERATE trial evaluating the effects of obeticholic acid in patients with pre-cirrhotic fibrosis due to metabolic dysfunction\u2013associated steatohepatitis, (2024).","DOI":"10.1016\/S0168-8278(24)00603-2"},{"key":"10.1016\/j.biopha.2025.118542_bib19","unstructured":"F.D.A., Ocaliva (obeticholic acid) by Intercept Pharmaceuticals: Drug Safety Communication - Serious Liver Injury Being Observed in Patients without Cirrhosis, 2024. \u3008https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/ocaliva-obeticholic-acid-intercept-pharmaceuticals-drug-safety-communication-serious-liver-injury\u3009."},{"issue":"8","key":"10.1016\/j.biopha.2025.118542_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118542_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118542_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jpba.2006.11.028","article-title":"Determination of reduced and oxidized glutathione in biological samples using liquid chromatography with fluorimetric detection","volume":"43","author":"Kand'ar","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.biopha.2025.118542_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ab.2012.01.030","article-title":"Assessment of reduced glutathione: comparison of an optimized fluorometric assay with enzymatic recycling method","volume":"423","author":"Rou\u0161ar","year":"2012","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.biopha.2025.118542_bib25","series-title":"Mitochondrial Physiology","author":"Gnaiger","year":"2020"},{"key":"10.1016\/j.biopha.2025.118542_bib26","series-title":"Mitochondrial Medicine: Volume I, Probing Mitochondrial Function","first-page":"9","article-title":"Isolation and quality control of functional mitochondria","author":"Hartwig","year":"2015"},{"issue":"13","key":"10.1016\/j.biopha.2025.118542_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136908","article-title":"Western diet decreases the liver mitochondrial oxidative flux of succinate: insight from a murine NAFLD model","volume":"22","author":"Sta\u0148kov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118542_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3181\/0707-MR-190","volume":"233","author":"Brenner","year":"2008","journal-title":"Mechanisms of Fibrogenesis, Experimental biology and medicine (Maywood, N.J.)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118542_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","article-title":"TGF-beta signal transduction: biology, function and therapy for diseases","volume":"3","author":"Tie","year":"2022","journal-title":"Mol. Biomed."},{"issue":"10","key":"10.1016\/j.biopha.2025.118542_bib30","doi-asserted-by":"crossref","first-page":"C1034","DOI":"10.1152\/ajpcell.00175.2012","article-title":"Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cells","volume":"303","author":"Xiao","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118542_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118542_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2025.102530","volume":"49","author":"Kumar","year":"2025","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118542_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118542_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A.S. Investigators, a randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118542_bib35","article-title":"P.B.C.S.G. The club epatologi ospedalieri \/associazione italiana gastroenterologi ed endoscopisti digestivi ospedalieri, Real-world experience with obeticholic acid in patients with primary biliary cholangitis","volume":"3","author":"D'Amato","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2025.118542_bib36","unstructured":"FDA, Hepatic Decompensation and Failure in Primary Biliary Cholangitis Patients with Cirrhosis, 2022. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/207999s008lbl.pdf\u3009."},{"issue":"6","key":"10.1016\/j.biopha.2025.118542_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cts.12421","article-title":"Modeling and experimental studies of obeticholic acid exposure and the impact of cirrhosis stage","volume":"9","author":"Edwards","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118542_bib38","article-title":"Obeticholic acid induces hepatoxicity via FXR in the NAFLD mice","volume":"13","author":"Lin","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118542_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101244","article-title":"Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease","volume":"51","author":"Xu","year":"2021","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2025.118542_bib40","first-page":"8119","article-title":"Obeticholic acid improves hepatic steatosis and inflammation by inhibiting NLRP3 inflammasome activation","volume":"10","author":"Yang","year":"2017","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118542_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbadis.2014.02.004","article-title":"FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model","volume":"1842","author":"Kunne","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA)Mol. Basis Dis."},{"issue":"11","key":"10.1016\/j.biopha.2025.118542_bib42","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.molmet.2017.09.001","article-title":"Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice","volume":"6","author":"Jouihan","year":"2017","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2025.118542_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/oby.21701","article-title":"Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice","volume":"25","author":"Haczeyni","year":"2017","journal-title":"Obes. (Silver Spring)"},{"key":"10.1016\/j.biopha.2025.118542_bib44","unstructured":"I.P. Inc., OCALIVA (Obeticholic acid) 5 mg and 10 mg Tablets Product Monograph, Mississauga, ON, 2018."},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI110668","article-title":"Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum","volume":"70","author":"Angelin","year":"1982","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300809","article-title":"Increased hepatoprotective effects of the novel farnesoid x receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis","volume":"19","author":"Adorini","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2025.118542_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","article-title":"Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"Tolbol","year":"2018","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.biopha.2025.118542_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fphar.2018.00410","article-title":"Progression and regression of hepatic lesions in a mouse model of NASH induced by dietary intervention and its implications in pharmacotherapy","volume":"9","author":"Ding","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118542_bib49","first-page":"2","article-title":"Mitochondrial pathways and respiratory control: an introduction to OXPHOS analysis","author":"Gnaiger","year":"2020","journal-title":"Bioenerg. Commun. 2020"},{"issue":"4","key":"10.1016\/j.biopha.2025.118542_bib50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"P\u00e9rez-Carreras","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118542_bib51","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118542_bib52","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1053\/j.gastro.2020.07.036","article-title":"FXR isoforms control different metabolic functions in liver cells via binding to specific DNA motifs","volume":"159","author":"Ramos Pittol","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118542_bib53","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","article-title":"Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion","volume":"274","author":"Chavin","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118542_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1388-1981(99)00195-X","article-title":"Upregulation of uncoupling protein 2 mRNA in genetic obesity: lack of an essential role for leptin, hyperphagia, increased tissue lipid content, and TNF-alpha","volume":"1484","author":"Memon","year":"2000","journal-title":"Biochim Biophys. Acta"},{"issue":"7","key":"10.1016\/j.biopha.2025.118542_bib55","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia\u2013reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.118542_bib56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-nutr-071715-050656","article-title":"Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus","volume":"36","author":"Koliaki","year":"2016","journal-title":"Annu Rev. Nutr."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500736X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500736X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:40:32Z","timestamp":1775781632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500736X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"alternative-id":["S075333222500736X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118542","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118542"}}